Publications by authors named "J M Norquist"

Claim this Profile
H
Health-related quality of life outcomes from KEYNOTE-412: chemoradiotherapy with or without pembrolizumab in participants with head and neck squamous cell carcinoma.
J-P Machiels, Y Tao, L Licitra, B Burtness, M Tahara, J M Norquist

Front Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life in participants with advanced biliary tract cancer from the randomized phase III KEYNOTE-966 study.
Changhoon Yoo, Makoto Ueno, Heinz-Josef Klümpen, Robin Kate Kelley, Arndt Vogel, Josephine M Norquist

J Hepatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility of evaluating AI-enabled digital symptom monitoring in metastatic patients with NSCLC receiving pembrolizumab therapy: A German single-arm observational pilot study.
Melissa L Santorelli, Oliver Schmalz, Mathias Hoiczyk, David Heigener, Clemens Schulte, Josephine M Norquist

Digit Health· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life analysis of the LEAP-002 study of lenvatinib plus pembrolizumab versus lenvatinib as first-line treatment for advanced hepatocellular carcinoma.
R S Finn, M Kudo, P Merle, T Meyer, S Qin, J M Norquist

ESMO Open· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the Content Validity of the COVID-19 Symptoms Daily Diary.
Jennifer Dine, Yanfen Guan, Mirline Milien, Claire Ervin, Dana D Byrne, Josephine M Norquist

Patient Relat Outcome Meas· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis